Flywheel, a Minneapolis-based medical imaging data and AI platform raises $54M in Series D funding, backed by tech giants including NVIDIA, Microsoft, and more.
Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development. Flywheel offers comprehensive solutions for pharma companies, providers, payers, system integrators, AI developers and academic medical centers to get optimum value out of their data assets.
The funding will fuel Flywheel’s continued growth in its two primary markets (public sector healthcare and pharmaceutical companies) while accelerating expansion in other markets, including providers, payers, system integrators, and software companies seeking to harness the value of their data for AI development. The funding will also help Flywheel extend its global reach into key geographies, particularly across Europe.
A novel vaccine that targets inflamed brain cells associated with Alzheimer’s disease may hold the key to potentially preventing or modifying the course of the
Flywheel Secures $54M for Medical AI Imaging Platform
by Jasmine Pennic Leave a Comment
What You Should Know:
New research highlights potential of cytisine for global smoking cessation efforts
A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s,
Clever Leaves CLVR stock And How CLVR gains profitability
Novel vaccine targets inflamed brain cells in Alzheimer’s to modify the course of disease
A novel vaccine that targets inflamed brain cells associated with Alzheimer’s disease may hold the key to potentially preventing or modifying the course of the